EP2507229
SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.6.2010:
5.10.2016:
10727241.1
:
31.5.2030
:
SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES
1.6.2010
5.10.2016
:
AbbVie Inc.:
1 North Waukegan Road, 60064, North Chicago, IL, US
:
PARK, Chang, H.:
WadsworthIllinois, US
:
BRUNCKO, Milan:
Green OaksIllinois, US
:
DING, Hong:
GurneeIllinois, US
:
DOHERTY, George A.:
LibertyvilleIllinois, US
:
ELMORE, Steven, W.:
NorthbrookIllinois, US
:
HASVOLD, Lisa:
GrayslakeIllinois, US
:
HEXAMER, Laura:
GrayslakeIllinois, US
:
KUNZER, Aaron:
Arlington HeightsIllinois, US
:
MANTEI, Robert, A.:
FranklinWisconsin, US
:
McCLELLAN, William, J.:
WaukeganIllinois, US
:
PARK, Cheol-Min:
GurneeIllinois, US
:
PETROS, Andrew, M.:
MundeleinIllinois, US
:
SONG, Xiaohong:
GrayslakeIllinois, US
:
SOUERS, Andrew, J.:
EvanstonIllinois, US
:
SULLIVAN, Gerard, M.:
Lake VillaIllinois, US
:
TAO, Zhi-Fu:
GurneeIllinois, US
:
WANG, Gary, T.:
LibertyvilleIllinois, US
:
WANG, Le:
Vernon HillsIllinois, US
:
WANG, Xilu:
GrayslakeIllinois, US
:
WENDT, Michael, D.:
Vernon HillsIllinois, US
:
HANSEN, Todd, M.:
GrayslakeIllinois, US
:
631404:
4.12.2009:
US
:
US2010036919:
1.6.2010
:
C07D 405/12, A61K 31/404, A61P 35/00, C07D 209/32, C07D 211/96, C07D 213/64, C07D 215/20, C07D 217/16, C07D 235/26, C07D 249/04, C07D 295/14, C07D 309/14, C07D 401/12, C07D 295/125, C07D 231/56, C07D 405/14